Navigation Links
Is RTA a new potential option for the treatment of hydatid cysts?
Date:7/24/2009

Current treatment of cystic echinococcosis is surgery or percutaneous aspiration, injection and reaspiration (PAIR) using hypertonic saline or ethanol. It is aimed at causing permanent damage to the endocyst - the thin, delicate, and translucid inner membrane that produces the cystic fluid and generates new larval elements able to expand the infestation. Surgery and PAIR on liver and lung can result in biliary or bronchial fistulae, prompted by endocyst detachment; chemical cholangitis or pneumonia, due to passing of hypertonic saline or ethanol into the biliary or bronchial tree; and infection or abscess on the residual cyst cavity.

A research article to be published on July 14, 2009 in the World Journal of Gastroenterology addresses a new, possible therapeutic approach to treating hydatid cysts as an alternative to surgery and PAIR.

Dr. Lamonaca and his group from the Mediterranean Institute for Transplantation and Advanced Therapies (ISMETT) in Palermo, Italy, experimented with the use of radiofrequency thermal ablation (RTA) to treat hydatid cysts. No controlled study of this kind has been reported in the literature. RTA is a technique that converts electric power passing through a needle placed in an organ tissue into released heat, which then causes tissue necrosis. This technique is currently used for treatment of neoplasms, primarily hepatocellular carcinoma.

The authors wanted to verify whether radiofrequency is able to warm and irreversibly damage hydatid cysts, causing cyst wall necrosis through a heat-related mechanism, and, secondly, whether the heat-related coagulative necrosis of the cyst wall allows the parasitic endocyst to remain attached to the pericystium, unlike surgery or PAIR, which invariably causes endocyst detachment.

RTA was performed on 17 cysts (9 hepatic and 8 pulmonary), and was followed by pathology examination. Necrosis of the endocyst with a 100% success rate was seen in both hepatic
'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
2. Mass. General team develops potentially safer general anesthetic
3. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential
4. Randall Terry, Founder, Operation Rescue: Abortion, Healthcare, and Social Upheaval: Pro-life Leaders to Discuss Backlash -- Including Potential of Unwanted Violence
5. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
6. Oral Piercings Pose Potential Health Care Risks
7. Study identifies potential fix for damaged knees
8. Researchers identify potential patient safety risks among methadone maintenance treatment patients
9. Pluronic L-81 is a potential anti-diabetic drug?
10. More than One-Third of Docs Say Risk Level Rising for Potential H1N1 Flu Pandemic
11. Huge Potential Returns for Healthcare Innovators

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ues increase by 247%, - Net loss reduced signi...rstCall/ - CRH Medical Corporation (CRM:TSX-V) ann...ine months ended September 30, 2009 (all figures a...d September 30, 2009, the Company reported a net l... for the three months ended September 30, 2008, an...
(Date:11/30/2009)...Newswire-FirstCall/ - AIM Health Group Inc. ("AIM"...d health care company, announced today that its ne...r 30, 2009 (the "Quarter") increased to $633,199 f...e time EBITDA(1) increased 290% to $910,734 from $...any also announced that revenues increased 87% to ...
(Date:11/30/2009)...ignificant impact, CBO analysis understates the ef...wire/ -- The Blue Cross and Blue Shield Associat...ng the estimate released today by the Congressiona...ed what many economists, actuaries, and health pol...care reform bill would make coverage more expensiv...
(Date:11/30/2009)... immune cells than sedentary, healthy adults , ,...udies have shown that exercise can help ward off h...s that the reason why may be found within cells th...omeres -- DNA at the tips of chromosomes that prot...althy, nonsmoking adults who did not exercise regu...
(Date:11/30/2009)...Nov. 30 Jedi Mind, Inc ...ased to announce the Company,s first thought-contr... The game, "Think-Tac-Toe" is the first of its kin... power of their mind and is geared towards people ...ce of $49 and can be purchased directly through th...
Breaking Medicine News(10 mins):Health News:CRH Medical reports Q3 2009 results 2Health News:CRH Medical reports Q3 2009 results 3Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2
... coloured, unconventional uniforms makes children ...ding to a study in the April issue of the Journal...versity of Florence, Italy, surveyed a total of 11...an average age of 10, were split into two groups o...
...s on Broader Product Distribution, Revenue Growth ...ecisionView, Inc., the leading provider of Clinica...ustry, today announced that its Board of Directors... Chairman for DecisionView. Scullion succeeds Stev...
...Proceeds Raised in a Follow-on Offering - , , - 1...a Receives Award for Best R&D Lease in ...oning Approved for Redevelopment Project in Cambri...ry - , , PASADENA, Calif., March 31 Alexandr...
...ers Tool to Calculate Your Personal Disability Quo...ard those "one in X people" stats countless times....t something is going to happen to? Now there,s a n...ity Quotient, or PDQ. , , This first-of-its-kind ...
.... (NYSE: CNO ), reported today that it has compl...dit facility. The changes made to the credit agre...he debt to capital ratio through June 30, 2010 to ... A decrease in the minimum risk based capital ...
...ifetime face greatest risk, experts say, , ...e exposure to radiation from CT scans can increase...vard University researchers report. , Widely used ...her radiation dose than most other imaging tests. ...
Other Medicine News:Health News:Multi-colored uniforms improve perceptions of hospital nurses among children and parents 2Health News:DecisionView Board of Directors Appoints James P. Scullion as CEO and President 2Health News:Alexandria Real Estate Equities Provides Update 2Health News:Alexandria Real Estate Equities Provides Update 3Health News:Alexandria Real Estate Equities Provides Update 4Health News:A New Number Everyone Should Know: Their PDQ 2Health News:Conseco Closes Amendment to Credit Facility 2Health News:Conseco Closes Amendment to Credit Facility 3Health News:Conseco Closes Amendment to Credit Facility 4Health News:As CT Radiation Accumulates, Cancer Risk May Rise 2Health News:As CT Radiation Accumulates, Cancer Risk May Rise 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Decub... Review ,, http://www.reportlinker.com/p01642...e-Market-Review.html ,, Decubitus Ulcers are ...stant pressure of the patient,s bodyweight. Pressu...
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswire/ -...e completion of a Phase I study of CPSI-2364, its ...duction of TNF-alpha and other pro-inflammatory cy...ose escalation study in healthy volunteers confirm...esting. ,, All 30 enrolled subjects completed...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Dr. Jocelyn R...Intervention at George Washington University Medic...cult lesions identified with Breast-Specific Gamma...odality imaging for needle biopsy as well, as for ...ting of the Radiological Society of North America ...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 1Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 3Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 1Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 2Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 3NIAID to fund new human immune profiling research centers 55152 1NIAID to fund new human immune profiling research centers 55152 2
...(TM) is evaluating zonisamide SR as a novel compon...EGO, June 07, 2007 /PRNewswire-FirstCall/ -- Orexi...ompany focused on the,treatment of central nervous..., today announced results from a Phase I trial eva...proprietary,sustained-release (SR) formulation of...
...ITY, Calif.--(BUSINESS WIRE)--Jun 6, 2007 - Gilead... Study 102, a,Phase III clinical trial evaluating ...ofovir disoproxil fumarate or tenofovir,DF) 300 mg...virus,(HBV) infection, met its primary efficacy en...r to the company,s once-daily antiviral,drug Hepse...
Other Medicine Technology:OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
Atria 6100
VASOVIEW® HemoPro™ Endoscopic Vessel Harvesting System
PM-9000 Express Patient Monitor
BC-3200 Auto Hematology Analyzer
Medicine Products: